Serial 88818421
Live / Registered — Registered (as of 20 Aug 2024)
What this means for you
Registered since 20 Aug 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88818421
- Registration number
- 7482429
- Mark type
- Design / logo
- Filed
- 03 Mar 2020
- Published for opposition
- 15 Sept 2020
- Registered
- 20 Aug 2024
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 001 — Chemicals: biological and chemical agents for scientific and research use, namely, for manipulating or modifying DNA
- Class 005 — Pharmaceuticals: pharmaceutical preparations, therapeutic preparations and pharmaceutical products, namely, for gene therapy and DNA editing; pharmaceutical and biological preparations based on gene, genome, and cellular editing, modulation, and modification for use in human therapeutics for the treatment of genomic disorders; pharmaceutical preparations, namely, therapeutic pharmaceuticals developed through genome modifications for the prevention and treatment of genomic disorders
- Class 042 — Scientific and technological services: development of technology for enabling the engineering and modification of DNA, namely, developing molecular and cellular biology reagents, techniques and assays for the modification of cells and DNA
Owner
- Tessera Therapeutics, Inc., Somerville, MA, US
- Tessera Therapeutics, Inc., Somerville, MA, US
- Tessera Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 20 Aug 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 20 Aug 2024 — REGISTERED-PRINCIPAL REGISTER
- 15 Jul 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 15 Jul 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 20 Jun 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 20 Jun 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 20 Jun 2024 — ASSIGNED TO LIE
- 01 Apr 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 03 Jan 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 03 Jan 2024 — NON-FINAL ACTION E-MAILED
- 03 Jan 2024 — SU - NON-FINAL ACTION - WRITTEN
- 14 Nov 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 10 Nov 2023 — USE AMENDMENT FILED
- 10 Nov 2023 — TEAS STATEMENT OF USE RECEIVED
- 16 May 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED